NCT03852823 2021-04-30Study of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced TumoursCSPC ZhongQi Pharmaceutical Technology Co., Ltd.Phase 1 Unknown192 enrolled